Financials
The Numbers
Edelweiss trades at 17x earnings and 2.3x book because the market sees a leveraged holding company with a 66% discount to management's sum-of-parts estimate, lumpy earnings driven by credit cycles, and persistent insurance losses dragging consolidated ROE to 8.7%. The single metric most likely to rerate this stock is corporate net debt – every Rs 1,000 Cr reduction mechanically adds Rs 80-100 Cr to holdco earnings and signals the value-unlock thesis is real.
Share Price (Rs)
Market Cap (Cr)
P/E Ratio
P/Book
ROE (%)
ROCE (%)
Dividend Yield (%)
Book Value / Share (Rs)
Price Context
The stock sits at Rs 108, 18% below its 52-week high of Rs 131 and 47% above the 52-week low of Rs 73.5. This mid-range positioning reflects the market's mixed conviction: the value-unlock story is alive but unproven.
Revenue and Earnings Power
Revenue peaked at Rs 11,078 Cr in FY2019 before the credit blowup, then collapsed as the wholesale lending book wound down. Post-restructuring revenue has stabilized around Rs 8,500-9,500 Cr, but the composition has shifted radically: from lending-dominated income to fee and insurance-premium income. Net income has recovered from the Rs 2,044 Cr FY20 loss to Rs 536 Cr in FY25, but remains well below the pre-crisis peak of Rs 1,044 Cr – a decade of earnings volatility that explains the market's skepticism.
Quarterly Trajectory
Q3 FY26 shows a notable revenue spike to Rs 4,404 Cr with Rs 270 Cr net income – the strongest quarter in two years. This likely reflects lumpy realization income from alternatives and/or one-time gains. Operating margins have been stable at 32-38%, and interest expense is trending down (Rs 656 Cr in Q2 FY24 to Rs 589 Cr in Q3 FY26), confirming the deleveraging story is translating to the income statement.
The Debt Deleveraging Story
Total debt has fallen 63% from its FY2018 peak of Rs 48,964 Cr to Rs 18,004 Cr in FY25. But leverage remains extreme at 4.1x D/E. The equity base itself shrank from Rs 6,883 Cr (FY18) to Rs 4,425 Cr (FY25) due to demergers (Nuvama) and accumulated losses, making the ratio look worse than the absolute debt reduction suggests.
The interest expense trajectory tells the real story. Annual interest cost has fallen from Rs 4,783 Cr (FY19) to Rs 2,537 Cr (FY25) – a Rs 2,246 Cr annual saving. This is the primary reason net income has recovered despite lower revenue. If corporate debt reaches near-zero as guided, another Rs 500-600 Cr of annual interest falls away, mechanically doubling current PAT.
Interest Burden – The Key Constraint
Interest expense consumed 50% of revenue at the FY20 peak. It now takes 27% – a structural improvement, but still an extraordinary drag for any financial services company. Peer Motilal Oswal pays interest equal to just 16% of revenue. This ratio must fall below 20% before the market treats Edelweiss as a fee-driven business rather than a leveraged credit play.
Cash Flow – Distorted by Lending Book Dynamics
Cash flow analysis for an NBFC holdco is misleading. The FY19-20 operating cash flow surge (Rs 5,685 Cr and Rs 12,098 Cr) was not operating excellence – it was the wholesale lending book running off. The FY25 OCF of Rs 2,052 Cr is more representative of normalized cash generation, but even this is distorted by insurance premium float and co-lending disbursements. The key cash flow metric for EFSL is not OCF but dividend upstream from subsidiaries, which was Rs 1,500 Cr cumulatively over the past two years.
Shareholding – FII Exodus, Retail Entry
FII holdings collapsed from 32.2% (FY23) to 18.4% (Q3 FY26) – a massive 14 percentage point exodus. DIIs absorbed some (2.7% to 5.7%), but retail/public investors picked up the bulk (27.7% to 43.2%). This institutional selling pressure is a warning: sophisticated foreign investors are leaving despite the low valuation, likely due to holdco complexity, governance concerns, or position sizing limits for a mid-cap with thin profitability.
EPS Trajectory – The Lost Decade
FY25 EPS of Rs 4.22 is below FY16's Rs 5.09 – a decade of zero per-share value creation. The FY20 blowup destroyed Rs 21.89 per share, and the partial dilution from subsequent capital raises means even a full recovery in absolute PAT does not translate to pre-crisis EPS. At Rs 108 share price, the market is paying 25.6x FY25 EPS on a trailing basis, not the headline 17.2x P/E (the gap is due to minority interest adjustments in consolidated earnings).
Peer Valuation Comparison
The scatter confirms the market is pricing Edelweiss rationally for its current ROE. JM Financial is the only peer cheaper on P/E (9.2x) and it has similar problems: diversified holdco with restructuring in progress, low ROE. The re-rating path requires ROE to move from 8.7% toward Motilal's 25% – which mathematically requires corporate debt near zero and insurance breakeven, both guided for FY27-28.
Revenue Growth – Edelweiss vs Motilal Oswal
This chart explains the valuation gap more than any ratio. Motilal Oswal grew revenue from Rs 2,450 Cr to Rs 8,340 Cr (3.4x) in six years while Edelweiss shrank from Rs 11,078 Cr to Rs 9,415 Cr. Edelweiss is a bigger business by revenue, but a shrinking one – the market pays for growth trajectories, not current scale.
Operating Margin Trend
Pre-crisis operating margins were 58-63%, driven by spread income on a large lending book. Post-restructuring margins have settled at 33-36%, reflecting the shift to a fee and insurance premium mix. This is structurally lower but also less volatile – fee income does not create credit losses. The margin expansion from here depends on insurance reaching breakeven (removing the loss drag) and scaling the mutual fund (operating leverage on AUM growth).
What the Numbers Confirm, Contradict, and Demand
The numbers confirm the deleveraging thesis is real: total debt has fallen 63% from peak, interest expense is down 47% from FY19, and ROCE is slowly recovering (5% in FY20 to 13% in FY25). They also confirm the holding company discount is earned, not arbitrary – 8.7% ROE, a lost decade of EPS growth, and massive FII exodus justify a cheap multiple.
The numbers contradict any claim that Edelweiss has already turned the corner. Revenue is stagnant, EPS is below FY16 levels, and the equity base has shrunk post-Nuvama demerger. The Q3 FY26 spike (Rs 4,404 Cr revenue, Rs 270 Cr PAT) is encouraging but needs to prove repeatable.
Watch next quarter: corporate net debt trajectory (target sub-Rs 5,000 Cr by Mar 2026), quarterly interest expense (should fall below Rs 500 Cr), and insurance losses (combined sub-Rs 40 Cr per quarter signals FY27 breakeven is real). The EAAA IPO timeline and pricing will be the most consequential single event for re-rating.